nifty-50

NIFTY 50

up

0.00

+0.00

nifty-50

GIFT NIFTY

up

0.00

+0.00

Background Grid Hero
Background Pattern Hero
Background Grid Hero
Background Pattern Hero
NSE Symbol: MARKSANS
Sector: NA
Industry: NA
Marksans Pharma Limited
0.00

Today's Low

0.00

Today's High

0.00

52 Week Low

0.00

52 Week High

0.00

image Fundamentals Analysis

Market Cap 0 Cr
Book Value 0.00
PE Ratio 0.00
PE for Sector 0.00
ROE 0.00 %
Dividend Yield 0.00 %
Open 0.00
52 Week High 0.00
52 Week Low 0.00
PB Ratio 0.00
ROCE 0.00 %
EPS 0.00

image About Company

image Quarterly Results

Consolidated Figures in Rs. Crores

Disclaimer

image Stock News - Marksans Pharma Limited [MARKSANS]

Quick Lookup
1W 0.00%
1M 0.00%
3M 0.00%
6M 0.00%
9M 0.00%
1Y 0.00%
Technical
RSI (14) 0.00
MACD (12,26) 0.00
Simple Moving Avg
5-SMA 0.00
10-SMA 0.00
20-SMA 0.00
50-SMA 0.00
100-SMA 0.00
200-SMA 0.00
Exponential Avg
50-EMA 0.00
100-EMA 0.00
200-EMA 0.00
Shareholding
shareholding-pattern
Promotors 0.00%
Public 0.00%
DII 0.00%
FII 0.00%

✨ Trendlyne Indicators ✨


Marksans Pharma Ltd.
Strengths right arrow 15 S
Weakness right arrow 5 W
Opportunity right arrow 6 O
Threats right arrow 1 T
What is SWOT Analysis ?
Strengths, Weaknesses, Opportunities and Threats Analysis is a real time check on stock health throughout the day. SWOT looks at financials, management quality, technical parameters and valuations to identify positives and negatives for every stock.
These are then classified as strengths, weaknesses, opportunities that investors can leverage, and threats that might impact company health.
  • Strengths
  • Weakness
  • Opportunity
  • Threats
  • Consistent Highest Return Stocks over Five Years
  • Relative Outperformance versus Industry over 1 Year
  • Companies with high TTM EPS Growth
  • PEG lower than Industry PEG
  • Relative Outperformance versus Industry over 1 Week
  • Growth in Net Profit with increasing Profit Margin (QoQ)
  • Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
  • Companies with Low Debt
  • Increasing Revenue every quarter for the past 3 quarters
  • Increasing profits every quarter for the past 3 quarters
  • Annual Net Profits improving for last 2 years
  • Book Value per share Improving for last 2 years
  • Companies with Zero Promoter Pledge
  • Top Gainers
  • Volume Shockers
  • Stocks with Expensive Valuations according to the Trendlyne Valuation Score
  • Inefficient use of shareholder funds - ROE declining in the last 2 years
  • Declining Net Cash Flow : Companies not able to generate net cash
  • Increasing Trend in Non-Core Income
  • Stocks Underperforming their Industry Price Change in the Quarter
  • Mutual Funds Increased Shareholding in Past Month
  • Highest FII stock holdings
  • FII / FPI or Institutions increasing their shareholding
  • MFs increased their shareholding last quarter
  • Mutual Funds Increased Shareholding over the Past Two Months
  • Mf buying for 2 months
  • US FDA Warning Letter
Trendlyne

QVT Stock Score

What is QVT right arrow
Marksans Pharma Ltd.
Quality 46 /100 Medium Financial Strength
Valuation 32 /100 Mid Valuation
Technicals 47 /100 Technically Neutral
Mid-range Performer
Good
Average
Bad
Trendlyne